Please provide your email address to receive an email when new articles are posted on . A functional precision medicine approach produced significant objective response, PFS in children with cancer.
Studies Demonstrate xCellSense® Platform's Ability to Predict Clinical Response and Enable Patient Stratification for Drug Development. PALO ALTO, Calif., Dec. 3, 2025 /PRNewswire/ -- ImpriMed, a ...
Women living with and without HIV, age 30-65 years, were recruited in South Africa. Self-collected vaginal samples and clinician-collected cervical samples were tested with Xpert HPV, an assay that ...
Diana Azzam is a co-founder and owns shares in First Ascent Biomedical. She receives funding from Florida Department of Health and National Institute of Health. Despite many efforts to find better, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results